Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia

This study has been completed.

Study NCT00017472 Information provided by National Cancer Institute (NCI)

First Received: June 6, 2001 Last Updated: February 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Leukemia
Lymphoma

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

apolizumab

Sponsors listed in this trial